Thomas D Marcotte
Overview
Explore the profile of Thomas D Marcotte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
4683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kulik M, Lee Y, Butsic V, Cermak T, Cooper Z, Corva D, et al.
Cannabis Cannabinoid Res
. 2024 May;
9(6):1463-1469.
PMID: 38717853
On April 28, 2023, the University of California Office of the President, in partnership with the California Department of Cannabis Control (DCC), hosted the California Cannabis Research Briefing. The California...
2.
Schuster N, Wallace M, Marcotte T, Buse D, Lee E, Liu L, et al.
medRxiv
. 2024 Feb;
PMID: 38405890
Background: Preclinical and retrospective studies suggest cannabinoids may be effective in migraine treatment. However, there have been no randomized clinical trials examining the efficacy of cannabinoids for acute migraine. Methods:...
3.
Marcotte T, Umlauf A, Grelotti D, Sones E, Mastropietro K, Suhandynata R, et al.
JAMA Psychiatry
. 2023 Aug;
80(9):914-923.
PMID: 37531115
Importance: With increasing medicinal and recreational cannabis legalization, there is a public health need for effective and unbiased evaluations for determining whether a driver is impaired due to Δ9-tetrahydrocannabinol (THC)...
4.
Fitzgerald R, Umlauf A, Hubbard J, Hoffman M, Sobolesky P, Ellis S, et al.
Clin Chem
. 2023 May;
69(7):724-733.
PMID: 37228223
Background: Cannabis is increasingly used both medically and recreationally. With widespread use, there is growing concern about how to identify cannabis-impaired drivers. Methods: A placebo-controlled randomized double-blinded protocol was conducted...
5.
Liyanage M, Nikanjam M, Capparelli E, Suhandynata R, Fitzgerald R, Marcotte T, et al.
Ther Drug Monit
. 2023 May;
45(5):689-696.
PMID: 37199428
Background: Despite its federally restricted status, cannabis is widely used medicinally and recreationally. The pharmacokinetics (PK) and central nervous system (CNS) effects of tetrahydrocannabinol (THC), the major psychoactive cannabinoid, are...
6.
Watson C, Sundermann E, Helm J, Paolillo E, Hong S, Ellis R, et al.
AIDS Behav
. 2023 May;
27(10):3401-3413.
PMID: 37155086
Cannabis use is rapidly increasing among older adults in the United States, in part to treat symptoms of common health conditions (e.g., chronic pain, sleep problems). Longitudinal studies of cannabis...
7.
Smith R, Sershen H, Janowsky D, Lajtha A, Grieco M, Gangoiti J, et al.
Front Psychiatry
. 2022 Jul;
13:887700.
PMID: 35859599
Background: Cannabis use is a component risk factor for the manifestation of schizophrenia. The biological effects of cannabis include effects on epigenetic systems, immunological parameters, in addition to changes in...
8.
Mosaed S, Smith A, Liu J, Minckler D, Fitzgerald R, Grelotti D, et al.
Front Med (Lausanne)
. 2022 Feb;
8:736792.
PMID: 35111768
Background: Δ9-tetrahydrocannabinol (THC) has been shown to decreased intraocular pressure (IOP). This project aims to define the relationship between plasma THC levels and IOP in healthy adult subjects. Methods: Eleven...
9.
Marcotte T, Umlauf A, Grelotti D, Sones E, Sobolesky P, Smith B, et al.
JAMA Psychiatry
. 2022 Jan;
79(3):201-209.
PMID: 35080588
Importance: Expanding cannabis medicalization and legalization increases the urgency to understand the factors associated with acute driving impairment. Objective: To determine, in a large sample of regular cannabis users, the...
10.
Gouse H, Masson C, Henry M, Dreyer A, Robbins R, Kew G, et al.
J Acquir Immune Defic Syndr
. 2022 Jan;
89(5):527-536.
PMID: 34974470
Background: The intellectually demanding modern workplace is often dependent on good cognitive health, yet there is little understanding of how neurocognitive dysfunction related to HIV presents in employed individuals working...